Evidence map›Paper›PMID 39487719›Full record

ReviewJournal of experimental botany2025

Advances in grape and pathogen genomics toward durable grapevine disease resistance.

Manon Paineau, Mirella Zaccheo, Mélanie Massonnet, Dario Cantu

Abstract readReview
In one paragraph

Review in Journal of experimental botany, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Manon PaineauDepartment of Viticulture and Enology, University of California Davis, Davis, CA 95616, USA.ORCID 0000-0001-6881-1203
Mirella ZaccheoDepartment of Viticulture and Enology, University of California Davis, Davis, CA 95616, USA.ORCID 0000-0003-4939-9764
Mélanie MassonnetDepartment of Viticulture and Enology, University of California Davis, Davis, CA 95616, USA.ORCID 0000-0003-0993-9148
Dario CantuDepartment of Viticulture and Enology, University of California Davis, Davis, CA 95616, USA.ORCID 0000-0002-4858-1508

Funding

National Institute of Food and Agriculture #2022-51181-38240US Department of Agriculture
6 · The paper itself

Abstract

The future sustainability of viticulture depends on the development of grapevine cultivars with genetic resistance to diseases such as powdery mildew, downy mildew, and Pierce's disease. Recent advances in grape and pathogen genomics have dramatically improved our approach to durable disease resistance. The availability of diploid genome references for wild species, combined with the ability to phase resistance haplotypes and conduct genome-wide association and expression analyses, has greatly enhanced our ability to dissect genetic resistance loci. This progress is yielding candidate genes that will form the foundation for precise breeding, gene stacking, and genome editing in grape improvement programs. As resistance genes are deployed in vineyards, pathogen populations evolve to adapt and evade these defenses, posing ongoing challenges. Understanding the adaptive mechanisms of grapevine pathogens in response to resistant cultivars is crucial. Grape pathogenomics is advancing rapidly, marked by the sequencing of many pathogen genomes, the discovery of effectors, including the first ones responsible for disease resistance breakdown, and the development of graph-based pangenomes. These advancements offer valuable insights into pathogen evolution and inform strategies for sustainable disease management. Together, these genomic tools and insights are paving the way for developing resilient grapevine varieties, ensuring the long-term sustainability of viticulture.

Indexed as

Disease ResistanceGenome, PlantGenomicsPlant DiseasesVitisDisease resistanceeffectorsgrape downy mildewgrape powdery mildewpathogenomicsphased genome assemblyPierce’s diseaseresistant gene stacking

Identifiers

PMID39487719
PMCPMC12321742

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.